Clinical Trial Update: Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)- Containing Supplement in Patients With Advanced Lung Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update evaluating the effect of a DHA/EPA-containing omega-3 supplement on nutritional and inflammatory status in patients with advanced lung can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• DHA/EPA-containing omega-3 supplement (docosahexaenoic acid and eicosapentaenoic acid)

Snippet

Sponsor: National Institute of Cancerología | Conditions: Lung Cancer | Phase 2, Phase 3 | Status: UNKNOWN